Vicor Corporation Reports Results for Third Quarter Ended September 30, 2014; Announces Appointment of H. Allen Henderson to Board of Directors

ANDOVER, MA — (Marketwired) — 10/21/14 — Vicor Corporation (NASDAQ: VICR) today reported financial results for the third quarter and nine months ended September 30, 2014. These results will be discussed later today at 5:00 p.m. Eastern Time, during management–s quarterly investor conference call. The details for the call are presented below. In addition, the Company announced today the appointment of H. Allen Henderson to its Board of Directors, effective October 18, 2014. Concurrent with a

Cascade Microtech to Announce Third Quarter Results on October 28, 2014 Conference Call Information

Cascade Microtech to Announce Third Quarter Results on October 28, 2014 Conference Call Information

BEAVERTON, OR — (Marketwired) — 10/21/14 — Cascade Microtech, Inc. (NASDAQ: CSCD) will release financial results for its third quarter ended September 30, 2014 at approximately 4:00 p.m. EDT (1:00 p.m. PDT), on Tuesday, October 28, 2014. The company will host a conference call beginning at 5:00 p.m. EDT (2:00 p.m. PDT) that same afternoon to discuss these results.A simultaneous audio cast of the conference call may be accessed online from the investor relations page at , or call: 877-415-318

Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure in United States

Hansen Medical Announces Completion of First Robot-Assisted Uterine Fibroid Embolization Procedure in United States

MOUNTAIN VIEW, CA — (Marketwired) — 10/21/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced the completion of the first robot-assisted Uterine Fibroid Embolization (UFE) in the United States. Sandeep Rao, MD, Interventional Radiologist, performed the procedure at Sierra Medical Center in El Paso, Texas using the Magellan Robotic System."I am extremely pleased by the outcome of this initial procedure," said Dr. Rao. "Robotic ca

Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs

Hansen Medical Appoints Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs

MOUNTAIN VIEW, CA — (Marketwired) — 10/20/14 — Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced it has named Brian Sheahan as Vice President of Clinical, Regulatory and Quality Affairs. Mr. Sheahan will report directly to Hansen–s President and Chief Executive Officer, Cary Vance."I–m delighted to announce Brian–s appointment as Vice President of Clinical, Regulatory and Quality Affairs," said Cary Vance, CEO. "Brian brings ext